Development and Validation of Nine Deprescribing Algorithms for Patients on Hemodialysis to Decrease Polypharmacy

BACKGROUND: Polypharmacy is ubiquitous in patients on hemodialysis (HD), and increases risk of adverse events, medication interactions, nonadherence, and mortality. Appropriately applied deprescribing can potentially minimize polypharmacy risks. Existing guidelines are unsuitable for nephrology clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Lefebvre, Melissa J., Ng, Patrick C. K., Desjarlais, Arlene, McCann, Dennis, Waldvogel, Blair, Tonelli, Marcello, Garg, Amit X., Wilson, Jo-Anne, Beaulieu, Monica, Marin, Judith, Orsulak, Cali, Lloyd, Anita, McIntyre, Caitlin, Feldberg, Jordanne, Bohm, Clara, Battistella, Marisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Clinical Research Quantitative
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605037/
https://www.ncbi.nlm.nih.gov/pubmed/33194213
http://dx.doi.org/10.1177/2054358120968674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605037/
https://www.ncbi.nlm.nih.gov/pubmed/33194213
http://dx.doi.org/10.1177/2054358120968674

Ejemplares similares